Christopher P. Regan

2.7k total citations
58 papers, 1.8k citations indexed

About

Christopher P. Regan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher P. Regan has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 23 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher P. Regan's work include Cardiac electrophysiology and arrhythmias (22 papers), Cardiac Arrhythmias and Treatments (10 papers) and Ion channel regulation and function (10 papers). Christopher P. Regan is often cited by papers focused on Cardiac electrophysiology and arrhythmias (22 papers), Cardiac Arrhythmias and Treatments (10 papers) and Ion channel regulation and function (10 papers). Christopher P. Regan collaborates with scholars based in United States, United Kingdom and Poland. Christopher P. Regan's co-authors include Gary K. Owens, Paul J. Adam, Cort S. Madsen, Joseph J. Lynch, Martina B. Hautmann, Ichiro Manabe, Gary L. Stump, Stephen J. Spatz, Wei Li and Diane M. Boucher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Christopher P. Regan

54 papers receiving 1.8k citations

Peers

Countries citing papers authored by Christopher P. Regan

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Regan more than expected).

Fields of papers citing papers by Christopher P. Regan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Regan. The network helps show where Christopher P. Regan may publish in the future.

Co-authorship network of co-authors of Christopher P. Regan

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Regan. A scholar is included among the top collaborators of Christopher P. Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Regan. Christopher P. Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model 2025 ·Journal of Pharmacological and Toxicological Methods ·John P. Imredy, Holly Clouse, Min Zhang, (unknown), Qiuwei Xu, (unknown), (unknown), (unknown), Christopher P. Regan	0
2	Characterization of a human wearable ECG device for continuous data collection in freely moving non-rodents 2025 ·Journal of Pharmacological and Toxicological Methods ·Christopher P. Regan, Alysia Chaves, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Recommendations on the measurement of electrocardiogram and hemodynamic parameters in restrained non-rodent species in regulatory safety assessment studies 2025 ·Journal of Pharmacological and Toxicological Methods ·Jean‐Pierre Valentin, Annie Delaunois, C. Michael Foley, (unknown), Pierre Lainée, Derek J. Leishman, Michael K. Pugsley, Sridharan Rajamani, Christopher P. Regan, Eric I. Rossman, Rebecca E. Ross, (unknown), Hugo M. Vargas, Todd Wisialowski	0
4	Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessments 2024 ·Journal of Pharmacological and Toxicological Methods ·Alysia Chaves, (unknown), Jing Yu, (unknown), (unknown), (unknown), (unknown), (unknown), Christopher P. Regan	1
5	A generalized canine transfer function accurately reconstructs central aortic pressure waveforms to enable enhanced pulse wave analysis 2023 ·Journal of Pharmacological and Toxicological Methods ·(unknown), (unknown), Julio A. Chirinos, Christopher P. Regan	2
6	Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor 2020 ·Journal of Pharmacology and Experimental Therapeutics ·Eric L. Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi‐Chung Li, Christopher P. Regan, Andrew Danziger, Maria S. Michener, Eric D. Hostetler, Pradeep Banerjee, Christopher Salvatore	51
7	Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay 2020 ·Toxicology and Applied Pharmacology ·Pierre Morissette, Sebastian Polak, Anne Chain, Jin Zhai, John P. Imredy, Mary Jo Wildey, (unknown), (unknown), (unknown), Elisa Passini, Blanca Rodríguez, Frederick Sannajust, Christopher P. Regan	5
8	Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene-Related Peptide Receptor (P4.10-021) 2019 ·Neurology ·Eric L. Moore, Christopher S. Burgey, Mark E. Fraley, Andrew Danziger, Christopher P. Regan, Chi‐Chung Li, Rebecca B. White, Pradeep Banerjee, Christopher Salvatore	2
9	QT interval correction assessment in the anesthetized guinea pig 2015 ·Journal of Pharmacological and Toxicological Methods ·Pierre Morissette, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Frederick Sannajust, Christopher P. Regan	12
10	Comparison of the Intrinsic Vasorelaxant and Inotropic Effects of the Antiarrhythmic Agents Vernakalant and Flecainide in Human Isolated Vascular and Cardiac Tissues 2012 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Christopher P. Regan, Gregory N. Beatch, Gilbert W. Gleim, Christopher Morabito	9
11	Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel 2010 ·Bioorganic & Medicinal Chemistry Letters ·Douglas C. Beshore, Nigel J. Liverton, Charles McIntyre, Christopher F. Claiborne, Brian E. Libby, Joseph Culberson, Joseph J. Salata, Christopher P. Regan, Joseph J. Lynch, László Kiss, Robert H. Spencer, (unknown), Rebecca B. White, Suzie Yeh, George D. Hartman, Christopher J. Dinsmore	12
12	Hemodynamic and Cardiac Neurotransmitter-releasing Effects in Conscious Dogs of Attention- and Wake-promoting Agents: A Comparison of d-Amphetamine, Atomoxetine, Modafinil, and a Novel Quinazolinone H3 Inverse Agonist 2009 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Christopher P. Regan, Gary L. Stump, Pamela L. Tannenbaum, Joanne Stevens, Ashleigh Bone, (unknown), (unknown), (unknown), Norihiro Takenaga, Shigeru Tokita, Tsuyoshi Nagase, Nagaaki Sato, John J. Renger	8
13	The Prototype Serotonin 5-HT1B/1D Agonist Sumatriptan Increases the Severity of Myocardial Ischemia During Atrial Pacing in Dogs With Coronary Artery Stenosis 2009 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Gary L. Stump, Stefanie A. Kane, Christopher P. Regan	8
14	Lack of Protection with a Novel, Selective Melanocortin Receptor Subtype-4 Agonist RY767 in a Rat Transient Middle Cerebral Artery Occlusion Stroke Model 2008 ·Pharmacology ·Christopher P. Regan, (unknown), Alison M. Strack, David H. Weinberg, Ravi P. Nargund, Zhixiong Ye, (unknown), Tung M. Fong, Ian J. Reynolds, Joseph J. Lynch	9
15	Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor 2008 ·Neuroscience Research ·Kelley A. Foster, (unknown), Andrew Danziger, (unknown), Nancy Kwon, Keith Rickert, Joseph J. Lynch, Christopher P. Regan	11
16	An improved automated method to quantitate infarct volume in triphenyltetrazolium stained rat brain sections 2007 ·Journal of Pharmacological and Toxicological Methods ·(unknown), (unknown), (unknown), Joseph J. Lynch, Christopher P. Regan	13
17	In Vivo Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker, (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide, in Rat and Nonhuman Primate 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Christopher P. Regan, Audrey A. Wallace, (unknown), Charity Atkins, Joseph J. Lynch	29
18	Novel Method to Assess Cardiac Electrophysiology in the Rat 2005 ·Journal of Cardiovascular Pharmacology ·Christopher P. Regan, (unknown), Rena Zhang, Joseph J. Lynch	18
19	In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Gary L. Stump, Audrey A. Wallace, Christopher P. Regan, Joseph J. Lynch	46
20	Interaction of CArG Elements and a GC-rich Repressor Element in Transcriptional Regulation of the Smooth Muscle Myosin Heavy Chain Gene in Vascular Smooth Muscle Cells 1997 ·Journal of Biological Chemistry ·Cort S. Madsen, Christopher P. Regan, Gary K. Owens	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact